Subacute sclerosing panencephalitis epidemiology and demographics

Subacute sclerosing panencephalitis Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Subacute sclerosing panencephalitis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Primary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Subacute sclerosing panencephalitis epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Subacute sclerosing panencephalitis epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Subacute sclerosing panencephalitis epidemiology and demographics
CDC on Subacute sclerosing panencephalitis epidemiology and demographics
Subacute sclerosing panencephalitis epidemiology and demographics in the news
Blogs on Subacute sclerosing panencephalitis epidemiology and demographics
Directions to Hospitals Treating Subacute sclerosing panencephalitis
Risk calculators and risk factors for Subacute sclerosing panencephalitis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Global patterns of infection

SSPE is an incredibly rare condition although there is still relatively high incidence in Asia and the Middle East. However, the number of reported cases is declining since the introduction of the measles vaccine — eradication of the measles virus prevents the SSPE mutation and therefore the progression of the disease or even the initial infection itself.

References

Template:WikiDoc Sources